CM
GILD icon

Capula Management’s Gilead Sciences GILD Stock Holding History

Capula Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6K Sell
100
-2,200
-96% -$290K ﹤0.01% 676
2026
Q1 		$321K Sell
2,300
-200
-8% -$28K ﹤0.01% 627
2025
Q4 		$307K Buy
2,500
+400
+19% +$48.6K ﹤0.01% 491
2025
Q3 		$233K Buy
2,100
+700
+50% +$79.6K ﹤0.01% 577
2025
Q2 		$155K Buy
+1,400
New +$149K ﹤0.01% 426
2023
Q3 		– Sell
-4,100
Closed -$316K – 568
2023
Q2 		$316K Sell
4,100
-54,500
-93% -$4.35M 0.01% 357
2023
Q1 		$4.86M Sell
58,600
-1,800
-3% -$149K 0.06% 240
2022
Q4 		$5.19M Sell
60,400
-360,100
-86% -$28.5M 0.07% 252
2022
Q3 		$25.9M Buy
420,500
+348,500
+484% +$22M 0.35% 68
2022
Q2 		$4.45M Buy
+72,000
New +$4.46M 0.08% 208
2021
Q2 		– Sell
-51,900
Closed -$3.35M – 812
2021
Q1 		$3.35M Buy
+51,900
New +$3.35M 0.07% 252

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capula Management's GILD Position: Q2 2026 in Review

Capula Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,147 shares worth $145K. The stake represents ﹤0.01% of the portfolio and ranks #580 among its holdings. This is a return to the name: Capula Management previously reported a position in GILD as recently as Q3 2025.

Capula Management first reported a position in GILD in Q3 2019 and has held it in 17 quarters since. The position peaked at $7.97M in Q3 2020. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Capula Management held 1,147 shares of Gilead Sciences worth $145K as of Q2 2026.
  • Gilead Sciences was a new Capula Management position in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of Capula Management's portfolio in Q2 2026, its #580 holding.
  • Capula Management first reported a position in Gilead Sciences in Q3 2019 and has held it in 17 quarters since.
  • Capula Management's Gilead Sciences position peaked at $7.97M in Q3 2020.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.